ASCO Explained: Expert predictions for the world’s biggest cancer meeting Jill O'Donnell-Tormey, CEO and Director of Scientific Affairs, is a panelist for the Fierce BioTech virtual roundtable. Cancer experts will highlight closely watched data sets to be unveiled at ASCO. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing. Moderator: Annalee Armstrong Senior Editor FierceBiotech Panelists: Jill O’Donnell-Tormey, PhD Chief Executive Officer and Director of Scientific Affairs Cancer Research Institute Jennifer Keating Litton, MD Vice President of Clinical Research and Professor The University of Texas MD Anderson Cancer Center Joseph Alvarnas, MD Vice President for Government Affairs, Chief Clinical Advisor AccessHope Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation City of Hope Photo by Wolfgang Hasselmann on Unsplash Read more: Post navigation Giving Tuesday 2020 Read Story Answer to Cancer x Peloton Ride Read Story